Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, Dr Lal PathLabs (LALPATHLAB.NS) has a market cap of $2.65 billion USD. According to our data, Dr Lal PathLabs is ranked No.3546 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $2.65 B |
-9.48%
|
| Dec 31, 2024 | $2.93 B |
17.66%
|
| Dec 29, 2023 | $2.49 B |
14.62%
|
| Dec 30, 2022 | $2.17 B |
-40.54%
|
| Dec 31, 2021 | $3.65 B |
66.87%
|
| Dec 31, 2020 | $2.19 B |
55.28%
|
| Dec 31, 2019 | $1.41 B |
65.80%
|
| Dec 31, 2018 | $0.85 B |
4.27%
|
| Dec 29, 2017 | $0.81 B |
-17.30%
|
| Dec 30, 2016 | $0.99 B |
33.46%
|
| Dec 31, 2015 | $0.74 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Quest Diagnostics
DGX
|
$18.18 B |
0.001 M
|
USA
|
 LabCorp
LH
|
$18.17 B |
0.001 M
|
USA
|
 Sea (Garena)
SE
|
$69.48 B |
5.508 B
|
Singapore
|
 OPKO Health
OPK
|
$1.13 B |
0.000 M
|
USA
|
 NeoGenomics
NEO
|
$1.23 B |
0.000 M
|
USA
|
 Fresenius Medical Care
FMS
|
$14.62 B |
0.743 B
|
Germany
|
 Hologic
HOLX
|
$12.99 B |
-0.000 M
|
USA
|
 Charles River Laboratories
CRL
|
$5.21 B |
0.000 M
|
USA
|
 Myriad Genetics
MYGN
|
$0.70 B |
0.000 M
|
USA
|
| Market Cap | = | LALPATHLAB.NS Stock Price | * | LALPATHLAB.NS Shares Outstanding |
| = | $31.78 | * | 83.37 M | |
| = | $2.65 B |